Home Cart Sign in  
Chemical Structure| 173334-57-1 Chemical Structure| 173334-57-1

Structure of Aliskiren
CAS No.: 173334-57-1

Chemical Structure| 173334-57-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Aliskiren is a renin inhibitor with IC50 of 1.5 nM.

Synonyms: SPP 100; CGP 60536; Aliskiren, Enviage, Rasilez, Riprazo, SPP100, Sprimeo

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Laurent David ; Mark Wenlock ; Patrick Barton ; Andreas Ritzén ;

Abstract: Chameleonic properties, i.e., the capacity of a molecule to hide polarity in non-polar environments and expose it in water, help achieving sufficient permeabilily and solubility for drug molecules with high MW.We present models ofexperimental measures of polarity for a set of 24 FDA approved drugs (MW 405-1113)and one PROTAC(MW 1034). Conformational ensembles in aqueous and non-polar environments were generated using molecular dynamics, A linearregression model that predicts chromatographic apparent polarity(EPSA) with a mean unsigned error of 10 A2 was derived based on separate terms for donor, acceptor, and tolal molecular SASA. A good correlation (R'0.92) with an experimental measure of hydrogen bond donor potential, Alog Poa, was found for the mean hydrogenbond donor SASA of the confommational ensemblescaled with Abraham's A hydrogen bond acidity. Two quantitative measures of chameleonic behaviour, the chameleonic efficlency indices, are introduced. We envislon that the methods presented herein will be useful to triage designed molecules and prioritize those with the best chance of achieving acceptable permeabilily and solubility.

Keywords: chameleonic properties ; polar surface area ; hydrogen bonding ; molecular dynamics

Purchased from AmBeed: ; ; ;

Alternative Products

Product Details of Aliskiren

CAS No. :173334-57-1
Formula : C30H53N3O6
M.W : 551.76
SMILES Code : CC(C)[C@@H](CC1=CC=C(OC)C(OCCCOC)=C1)C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(NCC(C)(C)C(N)=O)=O
Synonyms :
SPP 100; CGP 60536; Aliskiren, Enviage, Rasilez, Riprazo, SPP100, Sprimeo
MDL No. :MFCD09839018
InChI Key :UXOWGYHJODZGMF-QORCZRPOSA-N
Pubchem ID :5493444

Safety of Aliskiren

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • Renin

    Renin, IC50:1.5 nM

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Chronic intermittent hypoxia (CIH) model Intragastric gavage 20 mg/kg Once daily for 4 weeks To investigate the potential role of aliskiren in atrial remodeling in a chronic intermittent hypoxia (CIH) rat model. Results showed that aliskiren significantly attenuated CIH-induced atrial fibrosis and electrical remodeling, and reduced the inducibility of atrial fibrillation. PMC7502603
Wistar rats Cotton-pellet-induced granuloma and formaldehyde-induced paw edema models Oral 15, 30, 60 mg/kg Once daily for 7 days To evaluate the anti-inflammatory effects of aliskiren, results showed that aliskiren significantly reduced exudate, granuloma, and paw edema, and decreased serum levels of TNF-α, VCAM-1, and hs-CRP while restoring IL-10 levels. PMC7381093

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00865020 - Completed - -
NCT00841672 Moderate to Severe Hypertensio... More >>n Less << Phase 3 Completed - Germany ... More >> Investigative Site Berlin, Germany Philippines Investigative Site Manilla, Philippines Romania Investigative Site Bucharest, Romania Russian Federation Investigative Site Moscow, Russian Federation Singapore Investigative Site Singapore, Singapore Spain Investigative Site Madrid, Spain Less <<
NCT00841672 - Completed - -
NCT00219180 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers, Germany Less <<
NCT00219011 Heart Failure Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States Germany Investigative Centers, Germany Less <<
NCT01129557 Proteinuric Kidney Disease ... More >> Diabetic Nephropathy Hypertensive Nephrosclerosis IgA Nephropathy Focal Segmental Glomerulosclerosis Glomerulopathy (Obesity-associated) Glomerulonephritis, Membranous Less << Phase 4 Terminated - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00417170 High Blood Pressure ... More >> Metabolic Syndrome Insulin Resistance Endothelial Dysfunction Less << Phase 2 Completed - United States, California ... More >> Novartis Investigative Site Santa Monica, California, United States, 90404 Less <<
NCT00299832 Hypertension PHASE3 COMPLETED 2025-05-07 Novartis Pharmaceuticals, Japa... More >>n, Japan Less <<
NCT00299806 Hypertension PHASE3 COMPLETED 2025-11-06 Novartis Pharmaceuticals, Japa... More >>n, Japan Less <<
NCT01129557 - Terminated - -
NCT01048047 Hypertension Phase 4 Unknown March 2010 Italy ... More >> University of Pavia Pavia, Italy, 27100 University of Pavia Pavia, Italy Less <<
NCT00760266 Hypertension Phase 4 Completed - United States, New Jersey ... More >> Sites in USA East Hanover, New Jersey, United States, 07936 Less <<
NCT00865020 Hypertension Phase 4 Completed - Brazil ... More >> Investigative Site Sorocaba, Brazil Canada Investigative Site Gatineau, Canada Ecuador Investigative Site Guayaquil, Ecuador Germany Investigative Site Erfurt, Germany Hungary Invesitagtive Site Budapest, Hungary Korea, Republic of Investigative Site Cheongju, Korea, Republic of Malaysia Investigative Site Kuala Lumpur, Malaysia Mexico Investigative Site Mexico City, Mexico Panama Investigative Site Panama City, Panama Philippines Investigative Site Manila, Philippines Singapore Investigative Site Singapore, Singapore Slovakia Investigative Site Bratislava, Slovakia Spain Investigative Site Sevilla, Spain Turkey Investigative Site Istanbul, Turkey United Kingdom Investigative Site Westbury, United Kingdom Venezuela Investigative Site Caracas, Venezuela Less <<
NCT00870493 IgA Nephropathy Phase 3 Completed - Hong Kong ... More >> Prince of Wales Hospital Shatin, Hong Kong Less <<
NCT01125514 Heart Failure Phase 2 Completed - Germany ... More >> Novartis Investigative Site Berlin, Germany Lithuania Novartis Investigative Site Vilnius, Lithuania Less <<
NCT00386607 - Completed - -
NCT00461136 Diabetes Type 2 PHASE1|PHASE2 COMPLETED 2025-11-06 Novartis, Gentofte, 2820, Denm... More >>ark Less <<
NCT00417170 - Completed - -
NCT01125514 - Completed - -
NCT00819767 - Completed - -
NCT00386607 Hypertension Phase 3 Completed - United States, California ... More >> Investigative Centers San Diego, California, United States Canada Investigative Centers Canada, Canada Germany Investigative Centers Germany, Germany Netherlands Investigative Centers Netherlands, Netherlands Less <<
NCT00424541 Hypertension Phase 1 Completed - Japan ... More >> Novartis Investigative Site Tokyo, Japan, 160-8618 Less <<
NCT00819767 Hypertension Phase 2 Completed - Czech Republic ... More >> Investigative Site Pardubice, Czech Republic Investigative Site Prague, Czech Republic Hungary Investigative Site Budapest, Hungary Investigative Site Nyiregyhaza, Hungary Investigative Site Pilisvörösvár, Hungary Investigative Site Szentendre, Hungary Singapore Investigative Site Singapore, Singapore United Kingdom Investigative Site Leicester, United Kingdom Less <<
NCT00760266 - Completed - -
NCT00705575 Hypertension Phase 3 Completed - United States, New Jersey ... More >> Investigative Site East Hanover, New Jersey, United States, 07936 Argentina Investigative Site Buenos Aires, Argentina Ecuador Investigative Site Quito, Ecuador Germany Investigative Site Berlin, Germany Guatemala Investigative Site Guatemala City, Guatemala Italy Investigative Site Rome, Italy Switzerland Investigative Site Basel, Switzerland Turkey Investigative Site Ankara, Turkey Less <<
NCT00797862 Hypertension Phase 3 Completed - Canada ... More >> Investigative Site Toronto, Canada Costa Rica Investigative Site San Jose, Costa Rica France Investigative Site Paris, France Germany Investigative Site Bonn, Germany Greece Investigative Site Athens, Greece Guatemala Investigative Site Guatemala city, Guatemala South Africa Investigative Site Cape Town, South Africa Switzerland Investigative Site Basel, Switzerland United Kingdom Investigative Site London, United Kingdom Venezuela Investigative Site Caracas, Venezuela Less <<
NCT00705575 - Completed - -
NCT00923156 Heart Failure Phase 2 Completed - Germany ... More >> Novartis Investigator Site Bad Krozingen, Germany, 79189 Novartis Investigator Site Berlin, Germany, 12207 Novartis Investigator Site Berlin, Germany, 13353 Novartis Investigator Site Göttingen, Germany, 37057 Novartis Investigator Site Jena, Germany, 07747 Novartis Investigator Site München, Germany, 80336 Poland Novartis Investigator Site Krakow, Poland, 31-501 Novartis Investigator Site Lublin, Poland, 20-090 Novartis Investigator Site Poznan, Poland, 61-848 Novartis Investigator Site Warszawa, Poland, 02-507 Novartis Investigator Site Wroclaw, Poland, 50-981 Russian Federation Novartis Investigator Site Moscow, Russian Federation, 117292 Novartis Investigator Site Moscow, Russian Federation, 119620 Novartis Investigator Site Moscow, Russian Federation, 121309 Novartis Investigator Site Moscow, Russian Federation, 121552 Novartis Investigative Site Moscow, Russian Federation Less <<
NCT00402103 Hypertension Phase 3 Completed - United States, New Mexico ... More >> Investigative Site Santa Fe, New Mexico, United States Belgium Investigator Site Investigative Site, Belgium Denmark Investigative Center Investigative Center, Denmark Finland Investigative Site Investigative Site, Finland Germany Investigative Center Investigative Center, Germany Iceland Investigative Site Investigative Site, Iceland India Investigative Site Investigative Site, India Switzerland Investigative Site Investigative Site, Switzerland Less <<
NCT00797862 - Completed - -
NCT00343551 Essential Hypertension PHASE3 COMPLETED - Investigative Centers, Germany... More >>|Novartis Pharmaceuticals, Basel, Switzerland Less <<
NCT00867490 Hypertension Phase 3 Completed - Germany ... More >> Investigative Site Chemnitz, Germany Less <<
NCT00923156 - Completed - -
NCT00732407 Diabetes Mellitus ... More >> Atherosclerosis Less << Not Applicable Unknown - -
NCT01150357 - Completed - -
NCT00402103 - Completed - -
NCT00778921 - Completed - -
NCT00778921 Hypertension Phase 3 Completed - Argentina ... More >> Investigative Site Buenos Aires, Argentina Germany Investigative Site Berlin, Germany Norway Investigative Site Oslo, Norway Poland Investigative Site Warsaw, Poland Slovakia Investigative Site Bratislava, Slovakia Sweden Investigative Site Stockholm, Sweden Turkey Investigative Site Ankara, Turkey Less <<
NCT00777946 - Completed - -
NCT01150357 Hypertension Phase 3 Completed - -
NCT00927394 Hypertension Phase 4 Completed - United States, Delaware ... More >> Investigative Site Newark, Delaware, United States, USA United States, Missouri Investigative Site Kansas, Missouri, United States United States, New Jersey Investigative Site Camden, New Jersey, United States United States, Pennsylvania Investigative Site Philadelphia, Pennsylvania, United States Less <<
NCT00867490 - Completed - -
NCT00549757 Type 2 Diabetes Mellitus ... More >> Cardiovascular Disease Less << Phase 3 Terminated(Lack of benefit and... More >> safety concern) Less << - -
NCT00777946 Hypertension Phase 3 Completed - Estonia ... More >> Investigative site Estonia, Estonia France Investigative site France, France Iceland Investigative Site Iceland, Iceland India Investigative Site India, India Italy Investigative site Italy, Italy Korea, Republic of Investigative Site Republic of Korea, Korea, Republic of Lithuania Investigative Site Lithuania, Lithuania Spain Investigative Site Spain, Spain Venezuela Investigative Site Venezuela, Venezuela Less <<
NCT01080768 - Terminated(Publication of data... More >> from a similar study made the current study redundant.) Less << - -
NCT01893788 Hypertensive Left Ventricular ... More >>Hypertrophy Less << Phase 4 Unknown - Japan ... More >> Department of Cardiology, Nagoya University Graduate School of Medicine Recruiting Nagoya, Aichi, Japan, 466-8550 Contact: Takanori Nagahiro, MD    81-52-744-2149    t-nagahiro@med.nagoya-u.ac.jp    Contact: Toyoaki Murohara, MD, PhD    81-52-744-2149    murohara@med.nagoya-u.ac.jp Less <<
NCT00739596 Hypertension Phase 4 Completed - United States, New Jersey ... More >> Sites in USA East Hanover, New Jersey, United States Less <<
NCT01259297 - Terminated(Terminated early in... More >> agreement with Health Authorities for feasibility reasons) Less << - -
NCT00927394 - Completed - -
NCT01305850 Peritoneal Membrane Failure Phase 4 Unknown October 2011 Thailand ... More >> Chulalongkorn University Recruiting Bangkok, Thailand, 10330 Contact: Talerngsak Kanjanabuch, Assist. Prf.    662-2564321 ext 211    golfnephro@hotmail.com    Principal Investigator: Talerngsak Kanjanabuch, Assist. Prf.          Sub-Investigator: Pichaya Tantiyavarong, MD Less <<
NCT01070030 Stage II Hypertension Phase 4 Completed - Thailand ... More >> Investigative Site Bangkok, Thailand Investigative Site Chiang Mai, Thailand Investigative Site Nakhon Ratchasima, Thailand Less <<
NCT00881439 Heart Failure ... More >> Kidney Failure Less << Phase 2 Terminated(Futility) - Netherlands ... More >> University Medical Center Groningen Groningen, Netherlands Less <<
NCT01080768 Hypertension ... More >>Ankle Edema Less << Phase 2 Terminated(Publication of data... More >> from a similar study made the current study redundant.) Less << - Netherlands ... More >> Novartis Investigative Site Beek en Donk, Netherlands Novartis Investigative Site Bosch, Netherlands Novartis Investigative Site Den Haag, Netherlands Novartis Investigative Site Hoogwoud, Netherlands Novartis Investigative Site Lichtenvoorde, Netherlands Novartis Investigative Site Lieshout, Netherlands Novartis Investigative Site Poortvliet, Netherlands Novartis Investigative Site Utrecht, Netherlands Novartis Investigative Site Wildervank, Netherlands Less <<
NCT01259297 Cardiovascular Events Phase 3 Terminated(Terminated early in... More >> agreement with Health Authorities for feasibility reasons) Less << - -
NCT00549757 - Terminated(Lack of benefit and... More >> safety concern) Less << - -
NCT00739596 - Completed - -
NCT01165983 Diabetes Type 2 Not Applicable Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center, Joslin Foot Center & Microcirculation Laboratory Boston, Massachusetts, United States, 02215 Less <<
NCT00773084 Diastolic Heart Failure Not Applicable Withdrawn(Difficulty in recrui... More >>ting patients and then the PI left the institution) Less << August 2009 United States, Texas ... More >> Texas Tech University Health Sciences Center Lubbock, Texas, United States, 79430 Less <<
NCT00464776 Diabetes Mellitus, Type 2 Phase 1 Phase 2 Completed - Denmark ... More >> Novartis Gentofte, Denmark, 2820 Less <<
NCT01042392 - Completed - -
NCT00416728 Healthy Phase 1 Completed - United States, New Jersey ... More >> Novartis Investigative Site East Hanover, New Jersey, United States, 07936-1080 Less <<
NCT01042392 Essential Hypertension Phase 4 Completed - -
NCT00787605 Hypertension ... More >>Diabetes Mellitus Less << Phase 4 Completed - United States, New Jersey ... More >> Sites in USA East Hanover, New Jersey, United States, 07936 Less <<
NCT01165983 - Completed - -
NCT00416468 Healthy Phase 1 Completed - United States, New Jersey ... More >> Novartis Investigative Site East Hanover, New Jersey, United States, 07936-1080 Less <<
NCT00787605 - Completed - -
NCT00542269 - Terminated(Early termination o... More >>f the study due to slow recruitment.) Less << - -
NCT00542269 Hypertension With Metabolic Sy... More >>ndrome Less << Phase 4 Terminated(Early termination o... More >>f the study due to slow recruitment.) Less << - United Kingdom ... More >> Addenbrookes Hospital Cambridge, United Kingdom Less <<
NCT00464880 Diabetes Type 2 PHASE1|PHASE2 COMPLETED 2025-11-07 Novartis, Gentofte, 2820, Denm... More >>ark Less <<
NCT01067326 - Terminated(Novartis ended all ... More >>studies regarding Aliskiren.) Less << - -
NCT00933920 Hypertension Phase 1 Completed - India ... More >> Novartis Investigator Site Coimbatore, India Novartis Investigative Site Hyderabaad, India Novartis Investigator Site Hyderabaad, India Novartis Investigator Site Mangalore, India Novartis Investigative Site New Delhi, India Less <<
NCT01067326 Endothelial Dysfunction Phase 3 Terminated(Novartis ended all ... More >>studies regarding Aliskiren.) Less << - United States, Minnesota ... More >> Mayo Clinic in Rochester Rochester, Minnesota, United States, 55905 Less <<
NCT01302899 Non-diabetic Nephropathy Phase 2 Terminated(In consequence of t... More >>ermination of ALTITUDE. A number of studies were continued in consultation with the Altitude Data Monitoring Committee.) Less << - Netherlands ... More >> Novartis Investigative Site Groningen, Netherlands Novartis Investigative Site Leeuwarden, Netherlands Less <<
NCT00797316 Hypertension Phase 4 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT01302899 - Terminated(In consequence of t... More >>ermination of ALTITUDE. A number of studies were continued in consultation with the Altitude Data Monitoring Committee.) Less << - -
NCT01284114 Hypertension|Chronic Kidney Di... More >>sease Less << PHASE4 COMPLETED 2025-05-12 Niimi city Yukawa National hea... More >>lth insurance clinic, Niimi, Okayama, 719-2643, Japan|Konan Hospital, Oyama, Tochigi, 329-0214, Japan|Kurosu Hospital, Sakura, Tochigi, 329-1395, Japan|Jichi Medical University, Shimotsuke, Tochigi, 3290498, Japan Less <<
NCT01284114 Hypertension|Chronic Kidney Di... More >>sease Less << PHASE4 COMPLETED 2025-05-12 Niimi city Yukawa National hea... More >>lth insurance clinic, Niimi, Okayama, 719-2643, Japan|Konan Hospital, Oyama, Tochigi, 329-0214, Japan|Kurosu Hospital, Sakura, Tochigi, 329-1395, Japan|Jichi Medical University, Shimotsuke, Tochigi, 3290498, Japan Less <<
NCT00797316 - Completed - -
NCT01150201 Kidney Disease Phase 4 Completed - China ... More >> Queen Mary Hospital Hong Kong, China Less <<
NCT01237873 Essential Hypertension Phase 3 Completed - Japan ... More >> Novartis Investigative Site Yokohama, Kanagawa, Japan, 231-0023 Novartis Investigative Site Koshigaya city, Saitama, Japan, 343-0826 Novartis Investigative Site Edogawa-ku, Tokyo, Japan, 133-0061 Novartis Investigative Site Katsushika-ku, Tokyo, Japan, 124-0024 Novartis Investigative Site Kiyose, Tokyo, Japan, 204-0021 Novartis Investigative Site Kunitachi, Tokyo, Japan, 186-0001 Novartis Investigative Site Minato-ku, Tokyo, Japan, 105-7390 Novartis Investigative Site Minato-ku, Tokyo, Japan, 108-0075 Novartis Investigative Site Ota-ku, Tokyo, Japan, 143-0023 Novartis Investigative Site Shibuya-ku, Tokyo, Japan, 150-0002 Novartis Investigative Site Shinagawa-ku, Tokyo, Japan, 141-0032 Novartis Investigative Site Tachikawa, Tokyo, Japan, 190-0013 Novartis Investigative Site Toshima-ku, Tokyo, Japan, 171-0021 Less <<
NCT00853957 - Completed - -
NCT00768040 Diabetic Macular Edema Phase 2 Terminated(Inadequate enrollme... More >>nt) Less << - United States, Arizona ... More >> Retinal Consultants of Arizona Phoenix, Arizona, United States United States, California Retina-Vitreous Associates Los Angeles, California, United States United States, Florida National Ophthalmic Research Institute Fort Myers, Florida, United States United States, Georgia Georgia Retina Atlanta, Georgia, United States United States, Maryland Elman Retina Group Baltimore, Maryland, United States United States, Massachusetts Joslin Clinic Boston, Massachusetts, United States, MA United States, Michigan Vitreo-Retinal Associates Grand Rapids, Michigan, United States United States, North Carolina Charlotte Eye, Ear, Nose and Throat Associate Charlotte, North Carolina, United States, NC United States, Ohio Retina-Associates of Cleveland, Inc Beachwood, Ohio, United States United States, Texas Retinal Consultants of Houston Houston, Texas, United States, TX Denmark Novartis Investigative Site Arhus, Denmark Novartis Investigative Site Copenhagen, Denmark Less <<
NCT01715207 - Completed - -
NCT00853957 Hypertension Phase 4 Completed - United States, Illinois ... More >> Investigative Site Chicago, Illinois, United States United States, Maryland Investigative Site Baltimore, Maryland, United States Investigative Site Oxon Hill, Maryland, United States United States, Michigan Investigative Site Detroit, Michigan, United States United States, New Jersey Investigative Site Trenton, New Jersey, United States United States, New York Investigative Site Brooklyn, New York, United States Investigative Site Springfield Gardens, New York, United States United States, Pennsylvania Investigative Site Philadelphia, Pennsylvania, United States United States, Wisconsin Investigative Site Milwaukeee, Wisconsin, United States Less <<
NCT00894387 Acute Decompensated Heart Fail... More >>ure Congestive Heart Failure Less << Phase 3 Completed - -
NCT00768040 - Terminated(Inadequate enrollme... More >>nt) Less << - -
NCT00631917 Hypertension Phase 4 Completed - United States, Missouri ... More >> Investigative Site Kansas City, Missouri, United States Argentina Investigative Site Investigative Site, Argentina Colombia Investigative Site Investigative Site, Colombia France Investigative Site Investigative Site, France Germany Investigative Site Investigative Site, Germany India Investigative Site investigative Site, India Spain Investigative Site Investigative Site, Spain Less <<
NCT00939588 Hypertension Phase 2 Completed - Russian Federation ... More >> Novartis Investigative Site Moscow, Russian Federation Less <<
NCT00765947 Essential Hypertension ( Mild ... More >>to Moderate) Less << Phase 4 Completed - France ... More >> Investigative Site Paris, France Hungary Investigative Site Budapest, Hungary Romania Investigative Site Bucharest, Romania Slovakia Investigative Site Bratislava, Slovakia Less <<
NCT01060865 Blood Pressure, High PHASE4 TERMINATED 2025-12-11 Clalit health services, Hertsl... More >>iyah, Hasharon Area, Israel Less <<
NCT01827202 Hypertension ... More >>Chronic Kidney Disease Proteinuria Less << Phase 4 Completed - Austria ... More >> Medical University of Vienna, Department of Internal Medicine III, Division of Nephrology and Dialysis Vienna, Austria, 1090 Less <<
NCT00809926 Stage 2 Hypertension Phase 4 Completed - United States, New Jersey ... More >> Sites in USA East Hanover, New Jersey, United States, 07936 Less <<
NCT00894387 - Completed - -
NCT01715207 Marfan Syndrome Phase 3 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT00765947 - Completed - -
NCT00772577 Hypertension Phase 4 Completed - United States, California ... More >> Investigative Site Beverly Hills, California, United States Investigative Site Santa Ana, California, United States United States, Georgia Investigative Site Conyers, Georgia, United States United States, Kentucky Investigative Site Lexington, Kentucky, United States United States, South Carolina Investigative Site Columbia, South Carolina, United States United States, Texas Investigative Site Houston, Texas, United States Less <<
NCT00631917 - Completed - -
NCT00809926 - Completed - -
NCT00719316 Chronic Kidney Disease|Hyperte... More >>nsion|Muscle Sympathetic Nerve Activity Less << PHASE4 UNKNOWN 2025-01-10 University Medical Center utre... More >>cht, Utrecht, 3584CX, Netherlands Less <<
NCT00772577 - Completed - -
NCT00922311 IgA Nephropathy PHASE4 COMPLETED 2025-12-10 Department of Medicine, The Un... More >>iversity of Hong Kong, Hong Kong, China|Queen Mary Hospital, Hong Kong, China Less <<
NCT00834041 - Completed - -
NCT00853658 Chronic Heart Failure Phase 3 Completed - -
NCT01417104 Atherosclerosis Phase 2 Phase 3 Terminated(Safety concerns wit... More >>h approved medication identified in an unrelated trial) Less << - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00667719 Essential Hypertension Phase 3 Completed - United States, Texas ... More >> Investigative Site Houston, Texas, United States Belgium Investigative Site Belgium, Belgium Egypt Investigative Site Egypt, Egypt Germany Investigative Site Germany, Germany Poland Investigative Site Poland, Poland Slovakia Investigative Site Slovakia, Slovakia Spain Investigative Site Spain, Spain Turkey Investigative Site Turkey, Turkey Less <<
NCT00834041 Hypertension Phase 1 Phase 2 Completed - United States, Kentucky ... More >> Investigative Site Louisville, Kentucky, United States Belgium Investigative Site Brussels, Belgium Brazil Investigative Site Brasilia, Brazil Hungary Investigative Site Budapest, Hungary Poland Investigative Site Warsaw, Poland Less <<
NCT01176032 Hypertension ... More >>Left Ventricle Hypertrophy Less << Phase 4 Completed - Spain ... More >> Novartis Investigative Site Sanlúcar de Barrameda, Andalucia, Spain, 11540 Novartis Investigative Site Sevilla, Andalucia, Spain, 41009 Novartis Investigative Site Sevilla, Andalucia, Spain, 41013 Novartis Investigative Site Utrera, Andalucia, Spain, 41710 Novartis Investigative Site Burgos, Castilla y Leon, Spain, 09005 Novartis Investigative Site Barcelona, Cataluña, Spain, 08036 Novartis Investigative Site Girona, Cataluña, Spain, 17007 Novartis Investigative Site L'Hospitalet de Llobregat, Cataluña, Spain, 08907 Novartis Investigative Site Santa Coloma de Gramanet, Cataluña, Spain Novartis Investigative Site Alicante, Comunidad Valenciana, Spain, 03004 Novartis Investigative Site Torrevieja (Alicante), Comunidad Valenciana, Spain, 03186 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46010 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46014 Novartis Investigative Site Santiago de Compostela, Galicia, Spain, 15706 Novartis Investigative Site Galdakano, Pais Vasco, Spain, 48960 Novartis Investigative Site Bilbao, País Vasco, Spain, 48013 Novartis Investigative Site Vitoria, País Vasco, Spain Novartis Investigative Site Barcelona, Spain, 08006 Novartis Investigative Site Barcelona, Spain, 08025 Novartis Investigative Site Madrid, Spain, 28009 Novartis Investigative Site Madrid, Spain, 28035 Novartis Investigative Site Madrid, Spain, 28040 Novartis Investigative Site Madrid, Spain, 28041 Novartis Investigative Site Madrid, Spain, 28046 Novartis Investigative Site Santander, Spain, 39008 Less <<
NCT01409408 Hypertension ... More >>Diabetes Mellitus Less << Phase 4 Withdrawn(Due to preliminary r... More >>esults of Altitude Trial.) Less << December 2013 Brazil ... More >> Hospital Universitario Pedro Ernesto Rio de Janeiro, Brazil, 20551030 Less <<
NCT01417104 - Terminated(Safety concerns wit... More >>h approved medication identified in an unrelated trial) Less << - -
NCT00853658 - Completed - -
NCT01176032 - Completed - -
NCT00654875 Essential Hypertension Phase 4 Completed - United States, Ohio ... More >> Investigative Site Zanesville, Ohio, United States Germany Investigative Site Frankfurt, Germany Spain Investigative Site Valencia, Spain Less <<
NCT01113047 Essential Hypertension Phase 3 Completed - Germany ... More >> Investigative Site Pirna, Germany Less <<
NCT00654875 - Completed - -
NCT01472796 Hypertension Phase 4 Unknown March 2014 United States, Michigan ... More >> Wayne State University, 4201 St. Antoine Recruiting Detroit, Michigan, United States, 48201 Contact: Carol A Muzyk, CCRP    313-745-2378    cmuzyk@med.wayne.edu    Contact: Donna Ford    888-235-5467       Principal Investigator: John M Flack, M.D., M.P.H. Less <<
NCT00414609 Myocardial Infarction Phase 3 Completed - -
NCT01056731 High Blood Pressure Phase 4 Completed - Venezuela ... More >> Investigative Site Bolíva, Venezuela Investigative Site Carabobo, Venezuela Investigative Site Caracas, Venezuela Investigative Site Edo Zulia, Venezuela Investigative Site Estado Monagas, Venezuela Investigative Site Falcón, Venezuela Investigative Site Maracaibo Estado Zulia, Venezuela Less <<
NCT00414609 - Completed - -
NCT01318395 Arterial Hypertension Phase 3 Completed - Germany ... More >> Clinical Research Unit, Department of Nephrology and Hypertension, University of Erlangen-Nürnberg Erlangen, Germany, 91054 Clinical Research Unit, Department of Nephrology and Hypertension, University of Erlangen-Nürnberg Nürnberg, Germany, 90471 Less <<
NCT00498433 Hypertension ... More >>Abdominal Obesity Less << Phase 2 Terminated(Early termination r... More >>esulted from interim analysis of the ALTITUDE trial) Less << - Germany ... More >> Novartis Investigative Site Berlin-Buch, Germany, 13125 Novartis Investigative Site Hannover, Germany, 30159 Less <<
NCT00518765 Hypertension Phase 3 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT01922141 Hypertension Phase 4 Withdrawn June 2018 -
NCT00660309 Type 2 Diabetes Mellitus Phase 4 Completed - United States, Massachusetts ... More >> Novartis Investigator Site Boston, Massachusetts, United States, 02115 Less <<
NCT00498433 - Terminated(Early termination r... More >>esulted from interim analysis of the ALTITUDE trial) Less << - -
NCT00660309 - Completed - -
NCT00994253 Hypertension ... More >>Diabetes Type 2 Less << Phase 4 Withdrawn(Due to safety concer... More >>ns re the concomitant use of aliskiren with an ACEi or ARB.) Less << December 2012 United States, Michigan ... More >> William Beaumont Hospital Royal Oak, Michigan, United States, 48073 Less <<
NCT00942994 Hypertension Phase 4 Completed - United States, Arkansas ... More >> K and S Research Services Little Rock, Arkansas, United States, 72201 United States, Florida Well Pharma Medical Research South Miami, Florida, United States, 33143 United States, Massachusetts Hyde Park Health Associates Mattapan, Massachusetts, United States, 02126 United States, Virginia Manassas Clinical Research Center Manassas, Virginia, United States, 20110 United States, Washington Scriber Kidney Center Seattle, Washington, United States, 98133 Less <<
NCT01394770 Hypertension|Dialysis PHASE4 UNKNOWN 2025-09-12 Second Univesity of Naples, Na... More >>ples, 80100, Italy Less <<
NCT01040494 Congestive Heart Failure Phase 4 Unknown January 2011 Taiwan ... More >> National Taiwan University Hospital Not yet recruiting Taipei, Taiwan, 886 Contact: Lian-Yu Lin, MD, PhD    +886-2-23123456 ext 65002    lin7010@ms1.hinet.net    Principal Investigator: Lian-Yu Lin, MD, PhD          Taipei Veteral General Hospital Not yet recruiting Taipei, Taiwan, 886 Contact: Chen-Huan Chen, MD, PhD    +886-2-8712121 ext 2073    chench@vghtpe.gov.tw    Principal Investigator: Chen-Huan Chen, MD, PhD Less <<
NCT01219413 Chronic Kidney Disease ... More >> Proteinuria Blood Pressure Less << Phase 4 Completed - Poland ... More >> Medical University of Gdansk Gdansk, Pomorskie, Poland, 80-211 Less <<
NCT00441064 Hypertension PHASE4 COMPLETED 2025-11-07 Novartis US, Orangevale, Calif... More >>ornia, United States|Novartis US, Brooklyn Center, Minnesota, United States|Novartis US, Butte, Montana, United States|Novartis US, Missoula, Montana, United States|Novartis US, Lincoln, Nebraska, United States|Novartis US, Johnson City, New York, United States|Novartis US, Asheboro, North Carolina, United States|Novartis US, Shelby, North Carolina, United States|Novartis US, Cincinnati, Ohio, United States|Novartis US, Kettering, Ohio, United States|Novartis US, Downington, Pennsylvania, United States|Novartis US, Erie, Pennsylvania, United States|Novartis US, Pittsburg, Pennsylvania, United States|Novartis US, Dallas, Texas, United States|Novartis US, Kingsport, Texas, United States|Novartis US, Bountiful, Utah, United States|Novartis US, Salt Lake City, Utah, United States|Novartis US, Port Orchard, Washington, United States|Novartis US, Madison, Wisconsin, United States Less <<
NCT01095822 Diabetes Mellitus Phase 4 Unknown March 2011 United States, Maryland ... More >> Dr. Pokov's Polyclinic. 6821 Reisterstown Road Suite 206 Baltimore, Maryland, United States, 21215 Less <<
NCT00529451 - Completed - -
NCT00529451 Hypertension Phase 3 Completed - China ... More >> Novartis Investigative Sites China, China India Novartis Investigative Sites India, India Thailand Novartis Investigative Sites Thailand, Thailand Less <<
NCT00441064 Hypertension PHASE4 COMPLETED 2025-11-07 Novartis US, Orangevale, Calif... More >>ornia, United States|Novartis US, Brooklyn Center, Minnesota, United States|Novartis US, Butte, Montana, United States|Novartis US, Missoula, Montana, United States|Novartis US, Lincoln, Nebraska, United States|Novartis US, Johnson City, New York, United States|Novartis US, Asheboro, North Carolina, United States|Novartis US, Shelby, North Carolina, United States|Novartis US, Cincinnati, Ohio, United States|Novartis US, Kettering, Ohio, United States|Novartis US, Downington, Pennsylvania, United States|Novartis US, Erie, Pennsylvania, United States|Novartis US, Pittsburg, Pennsylvania, United States|Novartis US, Dallas, Texas, United States|Novartis US, Kingsport, Texas, United States|Novartis US, Bountiful, Utah, United States|Novartis US, Salt Lake City, Utah, United States|Novartis US, Port Orchard, Washington, United States|Novartis US, Madison, Wisconsin, United States Less <<
NCT02909166 Atrial Fibrillation Phase 3 Unknown December 2017 Finland ... More >> Helsinki University Central Hospital Recruiting Helsinki, Finland, 00029 Contact: Mika Lehto, MD, PhD    +358505447487    mika.lehto@hus.fi    Contact: Jussi Niiranen, MD       jussi.niiranen@hus.fi Less <<
NCT01519635 Hypertension Phase 4 Unknown October 2012 Switzerland ... More >> Centre Hospitalier Universitaire Vaudois Recruiting Lausanne, Vaud, Switzerland, 1004 Contact: Michel Burnier, Professor    0041213141129    michel.burnier@huv.ch    Sub-Investigator: Valentina Forni, MD Less <<
NCT02446548 Albuminuria Not Applicable Completed - Poland ... More >> Medical University of Gdansk Gdansk, Pomorskie, Poland, 80-211 Less <<
NCT01349114 - Terminated(Sponsor requested t... More >>ermination.) Less << - -
NCT01235910 Hypertension|Cardiac Transplan... More >>tation Less << PHASE4 TERMINATED 2025-12-12 University of Colorado Denver,... More >> Aurora, Colorado, 80045, United States Less <<
NCT01349114 Diabetes Pre-... More >>hypertension Hypertension Less << Phase 4 Terminated(Sponsor requested t... More >>ermination.) Less << - United States, Alabama ... More >> UAB Birmingham, Alabama, United States, 35294 Less <<
NCT00949351 Type 2 Diabetes With Nephropat... More >>hy Less << Phase 4 Unknown September 2010 Thailand ... More >> Lerdsin General Hospital Not yet recruiting Bangkok, Thailand, 10500 Contact: Krissanapong Manotham, Dr    662 3539799 ext 2501    kmanotham@hotmail.com    Contact: Tanaporn Ratanasuwan, Dr       tratanas@hotmail.com    Principal Investigator: Krissanapong Manotham, Dr Less <<
NCT00982033 - Completed - -
NCT01437943 Kidney Disease ... More >> Kidney Failure, Chronic Less << Phase 4 Terminated(Novartis has have d... More >>ecided to terminate all clinical investigator-initiated research projects involving aliskiren) Less << - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT01437943 - Terminated(Novartis has have d... More >>ecided to terminate all clinical investigator-initiated research projects involving aliskiren) Less << - -
NCT01093781 Idiopathic Membranous Nephropa... More >>thy Less << WITHDRAWN 2025-12-11 Mayo Clinic in Rochester, Roch... More >>ester, Minnesota, 55905, United States Less <<
NCT01480791 Hypertension ... More >>Diabetes Less << Phase 2 Withdrawn(Because of results o... More >>f Altitude trial, this trial was cancelled.) Less << - Canada, Quebec ... More >> Cardiovascular Prevention Centre, Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 Less <<
NCT01570686 Hypertension PHASE4 COMPLETED 2025-11-12 Novartis Investigative Site, L... More >>os Angeles, California, 90057, United States|Novartis Investigative Site, Riverside, California, 92506, United States|Novartis Investigative Site, Santa Monica, California, 90404, United States|Novartis Investigative Site, Walnut Creek, California, 94598, United States|Novartis Investigative Site, Westlake Village, California, 91361, United States|Novartis Investigative Site, Coral Gables, Florida, 33134, United States|Novartis Investigative Site, Miami, Florida, 33169, United States|Novartis Investigative Site, South Miami, Florida, 33143, United States|Novartis Investigative Site, Chicago, Illinois, 60607, United States|Novartis Investigative Site, Chicago, Illinois, 60610, United States|Novartis Investigative Site, Evansville, Indiana, 47712, United States|Novartis Investigative Site, Topeka, Kansas, 66606, United States|Novartis Investigative Site, Opelousas, Louisiana, 70570, United States|Novartis Investigative Site, Chaska, Minnesota, 55318, United States|Novartis Investigative Site, Edina, Minnesota, 55435, United States|Novartis Investigative Site, St. Paul, Minnesota, 55114, United States|Novartis Investigative Site, Jackson, Mississippi, 39209, United States|Novartis Investigative Site, Picayune, Mississippi, 39466, United States|Novartis Investigative Site, St. Louis, Missouri, 63141, United States|Novartis Investigative Site, Charlotte, North Carolina, 28209, United States|Novartis Investigative Site, Greensboro, North Carolina, 27401, United States|Novartis Investigative Site, Greensboro, North Carolina, 27408, United States|Novartis Investigative Site, Salisbury, North Carolina, 28144, United States|Novartis Investigative Site, Shelby, North Carolina, 28152, United States|Novartis Investigative Site, Winston-Salem, North Carolina, 27103, United States|Novartis Investigative Site, Cincinnati, Ohio, 45246, United States|Novartis Investigative Site, Columbus, Ohio, 43213, United States|Novartis Investigative Site, Lyndhurst, Ohio, 44124, United States|Novartis Investigative Site, Marion, Ohio, 43302, United States|Novartis Investigative Site, Norman, Oklahoma, 73069, United States|Novartis Investigative Site, Eugene, Oregon, 97404, United States|Novartis Investigative Site, Oregon City, Oregon, 97045, United States|Novartis Investigative Site, Portland, Oregon, 97239, United States|Novartis Investigative Site, Knoxville, Tennessee, 37920, United States|Novartis Investigative Site, Beaumont, Texas, 77702, United States|Novartis Investigative Site, Houston, Texas, 77081, United States|Novartis Investigative Site, Lake Jackson, Texas, 77566, United States|Novartis Investigative Site, Pasadena, Texas, 77504, United States|Novartis Investigative Site, Centerville, Utah, 84104, United States|Novartis Investigative Site, Arlington, Virginia, 22203, United States|Novartis Investigative Site, Ettrick, Virginia, 23803, United States|Novartis Investigative Site, Midlothian, Virginia, 23114, United States|Novartis Investigative Site, Port Orchard, Washington, 98366, United States|Novartis Investigative Site, Moncton, New Brunswick, E1G 1A7, Canada|Novartis Investigative Site, St. John's, Newfoundland and Labrador, A1A 3R5, Canada|Novartis Investigative Site, Brampton, Ontario, L6T 0G1, Canada|Novartis Investigative Site, Toronto, Ontario, M9W 4L6, Canada|Novartis Investigative Site, Mirabel, Quebec, J7J 2K8, Canada|Novartis Investigative Site, Sainte-Foy, Quebec, G1W 4R4, Canada|Novartis Investigative Site, Pozzilli, IS, 86077, Italy|Novartis Investigative Site, Pavia, PV, 27100, Italy|Novartis Investigative Site, Sassari, SS, 07100, Italy|Novartis Investigative Site, Carolina, 00983, Puerto Rico|Novartis Investigative Site, Cidra, 00739, Puerto Rico|Novartis Investigative Site, Manati, 00674, Puerto Rico|Novartis Investigative Site, Banská Bystrica, Slovak republic, 97405, Slovakia|Novartis Investigative Site, Bratislava, Slovak republic, 83299, Slovakia|Novartis Investigative Site, Kosice, Slovak Republic, 040 11, Slovakia|Novartis Investigative Site, Kosice, Slovak republic, 04001, Slovakia|Novartis Investigative Site, Nitra, Slovak republic, 95201, Slovakia|Novartis Investigative Site, Rimavska Sobota, Slovak republic, 97901, Slovakia|Novartis Investigative Site, Senec, Slovak republic, 90301, Slovakia|Novartis Investigative Site, Snina, Slovak republic, 09601, Slovakia|Novartis Investigative Site, Svidnik, Slovak Republic, 08901, Slovakia|Novartis Investigative Site, Trnava, Slovak republic, 91701, Slovakia|Novartis Investigative Site, Bratislava, 821 07, Slovakia|Novartis Investigative Site, Martin, 036 01, Slovakia|Novartis Investigative Site, Presov, 080 01, Slovakia|Novartis Investigative Site, Sala, 927 03, Slovakia|Novartis Investigative Site, Zvolen, 960 01, Slovakia|Novartis Investigative Site, Barcelona, Catalu?a, 08905, Spain|Novartis Investigative Site, Centelles, Catalu?a, 08540, Spain|Novartis Investigative Site, Corbera de Llobregat, Catalu?a, 08757, Spain|Novartis Investigative Site, Hostalets de Balenya, Catalu?a, 08550, Spain|Novartis Investigative Site, Vic, Catalu?a, 08500, Spain|Novartis Investigative Site, Alzira, Comunidad Valenciana, 46600, Spain|Novartis Investigative Site, Quart de Poblet, Comunidad Valenciana, 46930, Spain|Novartis Investigative Site, Madrid, 28009, Spain|Novartis Investigative Site, Taipei, Taiwan, ROC, 112, Taiwan|Novartis Investigative Site, Changhua, 500, Taiwan|Novartis Investigative Site, Taichung, 40447, Taiwan|Novartis Investigative Site, Taipei, 10002, Taiwan|Novartis Investigative Site, Taipei, 114, Taiwan Less <<
NCT01570686 Hypertension PHASE4 COMPLETED 2025-11-12 Novartis Investigative Site, L... More >>os Angeles, California, 90057, United States|Novartis Investigative Site, Riverside, California, 92506, United States|Novartis Investigative Site, Santa Monica, California, 90404, United States|Novartis Investigative Site, Walnut Creek, California, 94598, United States|Novartis Investigative Site, Westlake Village, California, 91361, United States|Novartis Investigative Site, Coral Gables, Florida, 33134, United States|Novartis Investigative Site, Miami, Florida, 33169, United States|Novartis Investigative Site, South Miami, Florida, 33143, United States|Novartis Investigative Site, Chicago, Illinois, 60607, United States|Novartis Investigative Site, Chicago, Illinois, 60610, United States|Novartis Investigative Site, Evansville, Indiana, 47712, United States|Novartis Investigative Site, Topeka, Kansas, 66606, United States|Novartis Investigative Site, Opelousas, Louisiana, 70570, United States|Novartis Investigative Site, Chaska, Minnesota, 55318, United States|Novartis Investigative Site, Edina, Minnesota, 55435, United States|Novartis Investigative Site, St. Paul, Minnesota, 55114, United States|Novartis Investigative Site, Jackson, Mississippi, 39209, United States|Novartis Investigative Site, Picayune, Mississippi, 39466, United States|Novartis Investigative Site, St. Louis, Missouri, 63141, United States|Novartis Investigative Site, Charlotte, North Carolina, 28209, United States|Novartis Investigative Site, Greensboro, North Carolina, 27401, United States|Novartis Investigative Site, Greensboro, North Carolina, 27408, United States|Novartis Investigative Site, Salisbury, North Carolina, 28144, United States|Novartis Investigative Site, Shelby, North Carolina, 28152, United States|Novartis Investigative Site, Winston-Salem, North Carolina, 27103, United States|Novartis Investigative Site, Cincinnati, Ohio, 45246, United States|Novartis Investigative Site, Columbus, Ohio, 43213, United States|Novartis Investigative Site, Lyndhurst, Ohio, 44124, United States|Novartis Investigative Site, Marion, Ohio, 43302, United States|Novartis Investigative Site, Norman, Oklahoma, 73069, United States|Novartis Investigative Site, Eugene, Oregon, 97404, United States|Novartis Investigative Site, Oregon City, Oregon, 97045, United States|Novartis Investigative Site, Portland, Oregon, 97239, United States|Novartis Investigative Site, Knoxville, Tennessee, 37920, United States|Novartis Investigative Site, Beaumont, Texas, 77702, United States|Novartis Investigative Site, Houston, Texas, 77081, United States|Novartis Investigative Site, Lake Jackson, Texas, 77566, United States|Novartis Investigative Site, Pasadena, Texas, 77504, United States|Novartis Investigative Site, Centerville, Utah, 84104, United States|Novartis Investigative Site, Arlington, Virginia, 22203, United States|Novartis Investigative Site, Ettrick, Virginia, 23803, United States|Novartis Investigative Site, Midlothian, Virginia, 23114, United States|Novartis Investigative Site, Port Orchard, Washington, 98366, United States|Novartis Investigative Site, Moncton, New Brunswick, E1G 1A7, Canada|Novartis Investigative Site, St. John's, Newfoundland and Labrador, A1A 3R5, Canada|Novartis Investigative Site, Brampton, Ontario, L6T 0G1, Canada|Novartis Investigative Site, Toronto, Ontario, M9W 4L6, Canada|Novartis Investigative Site, Mirabel, Quebec, J7J 2K8, Canada|Novartis Investigative Site, Sainte-Foy, Quebec, G1W 4R4, Canada|Novartis Investigative Site, Pozzilli, IS, 86077, Italy|Novartis Investigative Site, Pavia, PV, 27100, Italy|Novartis Investigative Site, Sassari, SS, 07100, Italy|Novartis Investigative Site, Carolina, 00983, Puerto Rico|Novartis Investigative Site, Cidra, 00739, Puerto Rico|Novartis Investigative Site, Manati, 00674, Puerto Rico|Novartis Investigative Site, Banská Bystrica, Slovak republic, 97405, Slovakia|Novartis Investigative Site, Bratislava, Slovak republic, 83299, Slovakia|Novartis Investigative Site, Kosice, Slovak Republic, 040 11, Slovakia|Novartis Investigative Site, Kosice, Slovak republic, 04001, Slovakia|Novartis Investigative Site, Nitra, Slovak republic, 95201, Slovakia|Novartis Investigative Site, Rimavska Sobota, Slovak republic, 97901, Slovakia|Novartis Investigative Site, Senec, Slovak republic, 90301, Slovakia|Novartis Investigative Site, Snina, Slovak republic, 09601, Slovakia|Novartis Investigative Site, Svidnik, Slovak Republic, 08901, Slovakia|Novartis Investigative Site, Trnava, Slovak republic, 91701, Slovakia|Novartis Investigative Site, Bratislava, 821 07, Slovakia|Novartis Investigative Site, Martin, 036 01, Slovakia|Novartis Investigative Site, Presov, 080 01, Slovakia|Novartis Investigative Site, Sala, 927 03, Slovakia|Novartis Investigative Site, Zvolen, 960 01, Slovakia|Novartis Investigative Site, Barcelona, Catalu?a, 08905, Spain|Novartis Investigative Site, Centelles, Catalu?a, 08540, Spain|Novartis Investigative Site, Corbera de Llobregat, Catalu?a, 08757, Spain|Novartis Investigative Site, Hostalets de Balenya, Catalu?a, 08550, Spain|Novartis Investigative Site, Vic, Catalu?a, 08500, Spain|Novartis Investigative Site, Alzira, Comunidad Valenciana, 46600, Spain|Novartis Investigative Site, Quart de Poblet, Comunidad Valenciana, 46930, Spain|Novartis Investigative Site, Madrid, 28009, Spain|Novartis Investigative Site, Taipei, Taiwan, ROC, 112, Taiwan|Novartis Investigative Site, Changhua, 500, Taiwan|Novartis Investigative Site, Taichung, 40447, Taiwan|Novartis Investigative Site, Taipei, 10002, Taiwan|Novartis Investigative Site, Taipei, 114, Taiwan Less <<
NCT01568775 End Stage Renal Disease PHASE1 COMPLETED 2025-09-10 Charité Universit?tsmedizin, B... More >>erlin, Germany Less <<
NCT00982033 Heart Failure Phase 4 Completed - United States, North Carolina ... More >> Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00942994 - Completed - -
NCT01235910 Hypertension|Cardiac Transplan... More >>tation Less << PHASE4 TERMINATED 2025-12-12 University of Colorado Denver,... More >> Aurora, Colorado, 80045, United States Less <<
NCT01298258 Heart Failure UNKNOWN 2025-07-13 Taipei Veterans General Hospit... More >>al, Taipei, Taiwan Less <<
NCT00262236 Hypertension PHASE3 COMPLETED 2025-08-06 Investigative Centers, Germany... More >>|Novartis, Basel, Switzerland Less <<
NCT00344110 Hypertension PHASE3 COMPLETED 2025-04-07 Novartis Pharmaceuticals, Japa... More >>n, Japan Less <<
NCT00294710 Hypertension PHASE3 COMPLETED 2025-07-06 Novartis, East Hanover, New Je... More >>rsey, 07936, United States|Investigative Centers, Germany Less <<
NCT00311012 Hypertension PHASE2 COMPLETED 2025-03-05 Novartis Pharmaceuticals, Toky... More >>o, Japan Less <<
NCT01156207 Heart Failure PHASE4 UNKNOWN - National Taiwan University Hos... More >>pital, Taipei, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.81mL

0.36mL

0.18mL

9.06mL

1.81mL

0.91mL

18.12mL

3.62mL

1.81mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories